INTR
TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
30/01/2026
Voltar para busca
Dado oficial do USPTO
E
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: MistaEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
41
Atualização mais recente
31/01/2026
Classificação
Registrada
Tipo de marca
Mista
Classes Nice
5, 42
Data de depósito
15/12/2016
Data de registro
13/11/2018
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
30/05/2025
Última transação
31/01/2026
Escritório responsável
United States Patent and Trademark Office
Código da situação
709
Cadastro oficial
Principal Register
Código do desenho
3
Tipo de titular
99
Localização do titular
GB
Examinador
TURNER, LAUREN
Unidade examinadora
N50
Localização atual
PUBLICATION AND ISSUE SECTION
Descrição da marca
The mark consists of patterns of dark and light green dots forming irregular circles, lines, and hexagons, all of which together form the letter "E"; several light green dots appear at random surrounding the "E". The color white represents the background, outlining, shading and/or transparent areas and is not part of the mark.
Titulares e representantes
Titulares
Evox Therapeutics Limited
Representantes
Susan Piasick Christoff Cooley LLP
Classificação técnica
Classes Nice
Classe 5Classe 42
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 5
Drug delivery agents in the form of exosomes that facilitate the delivery of pharmaceutical preparations; pharmaceutical preparationsa drug delivery system comprising genetically engineered or purified exosomes for transport of therapeutic agents; pharmaceutical preparationsengineered exosomes that deliver protein for genetic therapy; biological preparations comprising exosome for medical use; biological reagents comprising exosome for medical use; mixed biological preparations comprising exosome for pharmaceutical and medical use; diagnostic reagents comprising exosome for medicinal use in the fields of biologygenetic engineering and pharmaceuticals; pharmaceuticalsmedicinesbiologicsbiotherapeuticsbiosimilars and therapeuticsextracellular vesicle-based nucleic acid therapeutics for the prevention and treatment of infectious diseasescancerdiabetesobesitymetabolic syndromedementiamitochondrial diseaseneuromuscular diseaseinflammatory diseases and autoimmune disorders; diagnostic kits comprised of medical diagnostic reagents and assays for testing of exosomes for use in the detection of infectious diseasescancerdiabetesobesitymetabolic syndromedementiamitochondrial diseaseneuromuscular diseaseinflammatory diseases and autoimmune disorders
Classe 42
Scientificmedical and pharmaceutical research and development services; pharmaceutical drug development services; research and development of pharmaceutical preparations; biological research; clinical research in the field of transformational therapeutics; providing medical and scientific research information in the field of filtration of exosomes from blood; scientific investigations for medical purposes; scientific laboratory services; medical research laboratory services; laboratory research services relating to pharmaceuticals; research and development in the field of biotherapeutics for the treatment of infectious diseases and metabolic disorders; consulting services in the fields of biotechnologypharmaceutical research and development and genetic science
Publicações
Histórico de despachos e eventos da marca no USPTO.
41 publicações encontradas
C71T
CANCELLED SECTION 71
30/05/2025
REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
13/11/2023
NREP
NEW REPRESENTATIVE AT IB RECEIVED
04/12/2021
NREP
NEW REPRESENTATIVE AT IB RECEIVED
30/07/2020
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
08/03/2019
FICS
FINAL DISPOSITION NOTICE SENT TO IB
20/02/2019
FIMP
FINAL DISPOSITION PROCESSED
20/02/2019
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
13/02/2019
R.PR
REGISTERED-PRINCIPAL REGISTER
13/11/2018
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
28/08/2018
PUBO
PUBLISHED FOR OPPOSITION
28/08/2018
GPNX
NOTIFICATION PROCESSED BY IB
24/08/2018
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
08/08/2018
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
08/08/2018
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
08/08/2018
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
18/07/2018
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
27/06/2018
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
27/06/2018
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
27/06/2018
ADCH
CHANGE OF NAME/ADDRESS REC'D FROM IB
15/02/2018
ATRV
ATTORNEY REVIEW COMPLETED
31/01/2018
CREV
CORRECTION FROM IB ENTERED - ATTORNEY REVIEW REQUIRED
30/01/2018
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
11/01/2018
GNFR
FINAL REFUSAL E-MAILED
11/01/2018
CNFR
FINAL REFUSAL WRITTEN
11/01/2018
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
16/12/2017
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
15/12/2017
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
15/12/2017
CRCV
CORRECTION TRANSACTION RECEIVED FROM IB
15/12/2017
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
13/12/2017
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
13/12/2017
RFNT
REFUSAL PROCESSED BY IB
08/07/2017
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
17/06/2017
RFRR
REFUSAL PROCESSED BY MPU
17/06/2017
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
10/06/2017
CNRT
NON-FINAL ACTION WRITTEN
09/06/2017
MAFR
APPLICATION FILING RECEIPT MAILED
06/06/2017
DOCK
ASSIGNED TO EXAMINER
02/06/2017
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
02/06/2017
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
01/06/2017
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace E ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.